Syndax Pharmaceuticals (SNDX) Prepaid Assets (2015 - 2026)

Syndax Pharmaceuticals (SNDX) recorded quarterly Prepaid Assets of $16.1 million in Q1 2026, up 29172.73% quarter-over-quarter from $55000.0 in Q4 2025, and up 1563.22% on a YoY basis from $968000.0 in Q1 2025.

Syndax Pharmaceuticals (SNDX) Prepaid Assets (2015 - 2026) Analysis & Trends

Syndax Pharmaceuticals' Prepaid Assets history runs 12 years deep, the most recent figure standing at $16.1 million for Q1 2026.

  • In Q1 2026, Prepaid Assets rose 1563.22% year-over-year to $16.1 million; the TTM figure through Mar 2026 stood at $16.1 million (up 1563.22% YoY), while the FY2025 annual figure was $55000.0, down 48.6% from the prior year.
  • Prepaid Assets was $16.1 million for Q1 2026 at Syndax Pharmaceuticals, up from $55000.0 in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $16.1 million in Q1 2026 to a low of $55000.0 in Q4 2025.
  • Historically, Prepaid Assets has averaged $2.7 million across 5 years, with a median of $1.3 million in 2023.
  • The sharpest annual moves came in 2024 and 2025: Prepaid Assets slumped 96.75% in 2024, then jumped 7700.82% in 2025.
  • A 5-year view of Prepaid Assets shows it stood at $692000.0 in 2022, then jumped by 375.87% to $3.3 million in 2023, then plunged by 96.75% to $107000.0 in 2024, then slumped by 48.6% to $55000.0 in 2025, then soared by 29172.73% to $16.1 million in 2026.
  • The last three Prepaid Assets figures came in at $16.1 million (Q1 2026), $55000.0 (Q4 2025), and $9.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Syndax Pharmaceuticals 1.69 Bn 1.34 Bn 53.02 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 16.10 Mn
Dec 31, 2025 55,000.00
Sep 30, 2025 9.52 Mn
Jun 30, 2025 1.47 Mn
Mar 31, 2025 968,000.00
Dec 31, 2024 107,000.00
Sep 30, 2024 122,000.00
Jun 30, 2024 62,000.00
Mar 31, 2024 6.07 Mn
Dec 31, 2023 3.29 Mn
Sep 30, 2023 1.34 Mn
Jun 30, 2023 1.46 Mn
Mar 31, 2023 1.91 Mn
Dec 31, 2022 692,000.00
Sep 30, 2022 152,000.00
Jun 30, 2022 2.39 Mn
Mar 31, 2022 460,000.00
Dec 31, 2021 642,000.00
Sep 30, 2021 1.26 Mn
Jun 30, 2021 9.31 Mn